ACTUATE THERAPEUTICS, INC.（ACTU）内部人交易：高管与董事近期交易
过去 18 个月，共有 27 位内部人为 ACTUATE THERAPEUTICS, INC.（ACTU）报告了 30 笔 Form 4 交易（最近一笔 2026-08-14）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-14 | SCHMITT DANIEL M | President, CEO and Director | 买入 | 272,056 | $0 |
| 2026-08-14 | SCHMITT DANIEL M | President, CEO and Director | 卖出 | 120,521 | $121,726 |
| 2026-02-13 | SCHMITT DANIEL M | President, CEO and Director | 买入 | 272,055 | $0 |
| 2026-02-13 | SCHMITT DANIEL M | President, CEO and Director | 卖出 | 121,874 | $527,714 |
| 2026-01-07 | THOMSON TODD S | 董事 | 卖出 | 280,000 | $1.6M |
| 2026-01-07 | Kairos Venture Partners II, L.P. | 董事 | 卖出 | 280,000 | $1.6M |
| 2025-06-30 | BP Directors, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | Bios Clinical Opportunity Fund, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | Bios Equity COF, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | Bios 2024 Co-Invest, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Actuate Co-Invest I, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | Fletcher Aaron G.L. | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund II NT, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund III QP, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund III, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Advisors GP, LLC | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Capital Management, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Actuate Co-Invest II, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Equity Partners III, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | Bios Actuate Co-Invest III, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund I, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund I QP, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund II, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund II QP, LP | 董事 | 买入 | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund III NT, LP | 董事 | 买入 | 71,428 | $499,996 |
来源：SEC Form 4 申报文件 · 截至 2026-08-14